Nephrocare Health Services Ltd (NEPHROPLUS) โ Announcement | 31 August 2026
Nephrocare Health Services disclosed that its Uzbekistan subsidiary received a tax assessment order from the Tashkent City Tax Department dated August 24, 2026, demanding additional taxes of approximately โน11.50 crores and a penalty of โน3.29 crores totaling โน14.79 crores, arising from a revenue data discrepancy during a tax audit covering January 1, 2023 to December 31, 2025. The company believes the assessment stems from a mismatch between the tax authority's revenue figures and its audited records and preliminary data from the Ministry of Health, but maintains it satisfies the tax exemption criteria and expects the order to be set aside without material financial impact on its consolidated position.
About Nephrocare Health Services Ltd (NEPHROPLUS)
Healthcare ยท Healthcare ยท Listed on BSE
๐ก Get AI alerts when NEPHROPLUS files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track NEPHROPLUS โ Free๐ก Ask AI about this filing
๐ More NEPHROPLUS filings
- ๐ด Insider Trading โ 28 September 2026Polar Capital Funds PLC disclosed through its three healthcare-focused funds a 2.535% off-market pur...
- Announcement โ 25 September 2026Nephrocare Health Services Ltd announced the closure of its trading window effective October 1, 2026...
- ๐ด Announcement โ 22 September 2026Nephrocare Health Services Ltd announced it will attend an investor conference on September 29, 2026...
- ๐ด Announcement โ 18 September 2026Nephrocare Health Services announced that India Ratings upgraded its long-term bank loan facilities ...
- ๐ก Board Meeting โ 18 September 2026Nephrocare Health Services announced on September 18, 2026, that its board approved the rationalisat...
๐ฅ Also filed on 31 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when NEPHROPLUS files new disclosures
Track NEPHROPLUS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NEPHROPLUS โ FreeFree account ยท 2 AI queries/day